{"id":"W2035360235","doi":"10.1016/j.ctrv.2006.01.005","title":"Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence","year":2006,"lang":"en","type":"article","venue":"Cancer Treatment Reviews","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Adjuvant; Internal medicine; Chemotherapy; Stage (stratigraphy); Metastatic breast cancer; Monoclonal antibody; Cancer; Antibody; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002291223,0.0006912529,0.001373787,0.0001439643,0.0001665897,0.00007896041,0.0001731849,0.0001501793,0.001496487],"category_scores_gemma":[0.000009932557,0.0004628553,0.0006019143,0.0003934772,0.0001922051,0.0001757064,0.00003165227,0.0001602013,0.0001073484],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008277643,"about_ca_system_score_gemma":0.001376227,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01384968,"about_ca_topic_score_gemma":0.002105966,"domain_scores_codex":[0.9966652,0.0001806667,0.0007709755,0.001045417,0.000445799,0.000891921],"domain_scores_gemma":[0.9983466,0.0001060143,0.0002701335,0.0006997672,0.0002323351,0.0003451487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001944961,0.001525028,0.04947172,0.0008112694,0.0004384781,0.0001146462,0.0006628259,0.000006020991,0.0007766204,0.00002088073,0.01112181,0.9331058],"study_design_scores_gemma":[0.00529242,0.00306131,0.1751771,0.002695227,0.0009193748,0.00004043868,0.00003555267,0.00001195405,0.008060314,0.00002117862,0.8041495,0.0005355856],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.47395,0.4915389,0.00008243247,0.005135572,0.0008629719,0.01492012,0.006193355,0.0001655677,0.007151131],"genre_scores_gemma":[0.2904195,0.5820333,0.001683811,0.0008622535,0.003164763,0.06766719,0.0007141145,0.0002385233,0.0532165],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9325702,"threshold_uncertainty_score":0.9997823,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06632819832425466,"score_gpt":0.4043932864000384,"score_spread":0.3380650880757837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}